Curbside Consults

Rivaroxaban for Reducing Vascular Event Risks after Limb Revascularization for Peripheral Artery Disease – The VOYAGER PAD Trial with Dr. Marc Bonaca

05.29.2020 - By NEJM GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In today’s podcast we are joined by Dr. Marc Bonaca to discuss the findings of the recent VOYAGER PAD trial and the use of low-dose rivaroxaban in peripheral artery disease after revascularization.

More episodes from Curbside Consults